News | ACC | July 15, 2022

ACC Names Dr. Melvin Echols as Chief Diversity, Equity and Inclusion Officer

The ACC has named Melvin R. Echols, MD, FACC, as its new Chief Diversity, Equity and Inclusion Officer

Melvin R. Echols, MD, FACC 


July 15, 2022 — The ACC has named Melvin R. Echols, MD, FACC, as its new Chief Diversity, Equity and Inclusion Officer, effective July 18. Echols will lead the College’s diversity, equity and inclusion strategy and programs, while also maintaining a portion of his current clinical and research responsibilities at Morehouse School of Medicine in Atlanta. 

"Fostering a diverse and inclusive cardiovascular workforce, while also advancing solutions to improve health equity among individual patients and populations, is fundamental to achieving ACC’s Mission of transforming cardiovascular care and improving heart health for all,” said ACC CEO Cathleen C. Gates. “As both a cardiologist and a cardiovascular disparities researcher, Dr. Echols brings a deep understanding of the profession, as well as demonstrated success in effectively advancing diversity, equity and inclusion initiatives and driving cultural change – competencies that will undoubtedly ensure we are able to deliver on our strategic diversity, equity and inclusion goals now and into the future.” 

Echols is currently an associate professor of cardiovascular disease at Morehouse School of Medicine and serves as program director for the Cardiovascular Disease Fellowship. He is also a practicing cardiologist specializing in heart failure and brings more than a decade of experience as a clinical trial investigator focusing on heart failure, quality improvement, social determinants of health, and health care disparities. In his role as Chief Diversity, Equity and Inclusion Officer, Echols will use his expertise and experiences to work with ACC members, staff, external partners and other stakeholders to identify and implement programmatic goals and develop actionable and sustainable solutions to achieving a more diverse, equitable and inclusive College and cardiovascular profession. Specifically, he will lead and facilitate ACC efforts to mitigate barriers to entry into the field of cardiology; build and expand educational initiatives like the new Internal Medicine Program; and lead and coordinate the diversity and inclusion efforts and training of both staff and members across the College. 

“In a time where polarization continues to permeate our society, we need the implicit core values of diversity, equity, and inclusion now more than ever,” Echols said. “I expect this role will permit me to listen actively, learn vigorously, and allow the needs of our society to lead the ACC towards impactful change.” 

Echols graduated from Morehouse School of Medicine in 2002 and completed Internal Medicine at Duke University in 2005. He completed his cardiovascular fellowship training at Duke University Medical Center. He is a member of the ACC, Association of Black Cardiologists, the Heart Failure Society of America, the American Society of Preventive Cardiology, and the American Heart Association

“The discovery of commonalities between people and culture while providing quality cardiovascular care to all is strengthened by diversity, and will ultimately improve health equity in our society,” Echols said. “Everyone has a part to play in this mission and should feel included in helping to make our society and the world better than yesterday.” 

For more information: www.acc.org 

Find more ACC22 conference coverage 


Related Content

News | Heart Failure

June 27, 2024 — The human body has sophisticated defenses against the deposition of calcium minerals that stiffen heart ...

Home June 27, 2024
Home
News | Heart Failure

June 24, 2024 — Endotronix, Inc., a privately held company dedicated to advancing the treatment of heart failure (HF) at ...

Home June 24, 2024
Home
News | Heart Failure

June 18, 2024 — As we commemorate Juneteenth 2024, JACC, the flagship journal of the American College of Cardiology, has ...

Home June 18, 2024
Home
News | Heart Failure

June 7, 2024 — Calcific aortic valve disease (CAVD) is the major heart valve disease that afflicts nearly 10 million ...

Home June 07, 2024
Home
News | Heart Failure

June 7, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home June 07, 2024
Home
News | Heart Failure

May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with ...

Home May 28, 2024
Home
News | Heart Failure

May 22, 2024 — New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical ...

Home May 22, 2024
Home
News | Heart Failure

April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College ...

Home April 30, 2024
Home
News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
Subscribe Now